業績

HOME > 業績 > 2024年

業績

HOME > 業績 > 2024年

2024年

2024年7月現在

原著論文: 症例報告を含む

1.	Kobayashi N, Tanaka K, Muraoka S, Somekawa K, Kaneko A, Kubo S, Matsumoto H, Fujii H, Watanabe K, Horita N, Hara Y, Kaneko T: Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients. J Infect Chemother, 30: 48-52, 2024.
2.	Kashizaki F, Chen H, Miyasaka A, Tsuchiya N, Yamada C, Okazaki S, Kaneko M, Kano T, Kameda Y, Kikuchi A, Yumoto K, Osawa H, Koizumi H, Takahashi K, Kaneko T: Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis. Clin Lung Cancer, 25: e52-e57, 2024.
3.	Hirata M, Hara Y, Fujii H, Murohashi K, Saigusa Y, Zhao S, Kobayashi M, Nagasawa R, Tagami Y, Izawa A, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T: ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases. BMC Pulm Med, 24:16, 2024.
4.	Motobayashi Y, Oshikata C, Kodama Y, Terada K, Yamashita Y, Nakadegawa R, Masumitsu H, Osada R, Takayasu H, Masumoto N, Manabe S, Kaneko T, Shiraishi A, Tsurikisawa N: Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis. Respir Med Case Rep, 47: 101980, 2024.
5.	Yamada C, Kashizaki F, Kaneko M, Kitaji D, Kawano N, Kaneko T: Hemodialysis requirement after the first dose of durvalumab following chemoradiation therapy: a case report. Anticancer Drugs, 35: 199-202, 2024.
6.	Fukuda Y, Horita N, Aga M, Kashizaki F, Hara Y, Obase Y, Niimi A, Kaneko T, Mukae H, Sagara H: Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis. Respir Investig, 62: 206-215, 2024.
7.	Osada R, Oshikata C, Kurihara Y, Terada K, Kodama Y, Yamashita Y, Nakadegawa R, Masumitsu H, Motobayashi Y, Takayasu H, Masumoto N, Manabe S, Zhu Y, Tanaka R, Kaneko T, Sasaki A, Tsurikisawa N: A Case of Type I Food Allergy Induced by Monosodium Glutamate. J Asthma Allergy, 17: 161-165, 2024.
8.	Kashizaki F, Konishi K, Yamada C, Okazaki S, Chen H, Miyasaka A, Tsuchiya N, Kikuchi A, Yumoto K, Kojima Y, Osawa H, Koizumi H, Takahashi K, Kaneko T: Successful excision of an inflammatory endobronchial polyp using biopsy forceps with improvement in FEV1 in a patient with allergic bronchopulmonary aspergillosis: A case report. Respir Med Case Rep, 48: 102011, 2024.
9.	Izawa A, Hara Y, Horita N, Muraoka S, Kaneko M, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Tanaka K, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Kobayashi N, Miura K, Nakajima H, Kaneko T: Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel. Transl Lung Cancer Res, 13: 503-511, 2024.
10.	Yamada K, Takeuchi M, Fukumoto T, Suzuki M, Kato A, Mizuki Y, Yamada N, Kaneko T, Mizuki N, Horita N: Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis. Sci Rep, 14:7887, 2024.
11.	Fujii H, Hara Y, Obase Y, Haranaga S, Takahashi H, Shinkai M, Terada J, Ikari J, Katsura H, Yamamoto K, Suzuki T, Tagaya E, Mukae H, Kaneko T: Nationwide survey in Japan of the causative diseases of bloody sputum and hemoptysis in departments of respiratory medicine at university hospitals and core hospitals. Respir Investig, 62:395-401, 2024.
12.	Kaneko A, Kobayashi N, Miura K, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Watanabe K, Horita N, Hara Y, Kudo M, Miyazawa N, Kaneko T: Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thorac Cancer, 15:1208-1217, 2024.
13.	Tagami Y, Horita N, Kaneko M, Muraoka S, Fukuda N, Izawa A, Kaneko A, Somekawa K, Kamimaki C, Matsumoto H, Tanaka K, Murohashi K, Aoki A, Fujii H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis. J Infect Dis, 229: 1481-1492,2024.
14.	Yamashita Y, Terada K, Kodama Y, Nakadegawa R, Masumitsu H, Motobayashi Y, Osada R, Takayasu H, Masumoto N, Kaneko T, Tsurikisawa N. Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease. Respir Med Case Rep, 50: 102041, 2024.
15.	Takeuchi K, Abo M, Date H, Gotoh S, Kamijo A, Kaneko T, Keicho N, Kodama S, Koinuma G, Kondo M, Masuda S, Mori E, Morimoto K, Nagao M, Nakano A, Nakatani K, Nishida N, Nishikido T, Ohara H, Okinaka Y, Sakaida H, Shiraishi K, Suzaki I, Tojima I, Tsunemi Y, Kainuma K, Ota N, Takeno S, Fujieda S: Practical guide for the diagnosis and management of primary ciliary dyskinesia. Auris Nasus Larynx, 51:553-568, 2024.
16.	Yamamoto S, Horita N, Hara J, Sasamoto M, Kanemitsu Y, Hara Y, Obase Y, Kaneko T, Niimi A, Mukae H: Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough: Dose-Response Model-Based Network Meta-Analysis. Chest, S0012-3692(24)00693-7, 2024.[Online ahead of print]
17.	Kashizaki F, Konishi K, Chen H, Tanaka A, Miyasaka A, Okazaki S, Yamada C, Tsuchiya N, Yumoto K, Koizumi H, Takahashi K, Kaneko T: Pretreatment asthma control test score as a predictive score for clinical remission after bronchial thermoplasty in younger patients with severe asthma and preserved lung function. J Asthma, 61: 663-670, 2024.
18.	Kaneko T, Sekine A, Komatsu S, Otoshi R, Haga S, Tagami Y, Kaneko T, Ogura T: Successful pembrolizumab treatment for microsatellite instability-high thymoma: A case report. Respir Investig, 62: 517-519, 2024.
19.	Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, Terai H, Tanaka K, Sato S, Hagiwara E, Takei R, Kondoh Y, Takazono T, Hashimoto M, Tasaka S, Ohrui T, Tanino Y, Mineshita M, Komase Y, Miyazaki K, Nishikawa M, Ando A, Kita H, Ichihara E, Ohshimo S, Murata Y, Ishida M, Kobayashi S, Uchida T, Tateno H, Ikari J, Terashima T, Kozu Y, Tateishi T, Shinkai M, Sagara H, To Y, Ito Y, Yamamoto M, Yamamoto Y, Kita T, Ito Y, Tomii K, Fujita Y, Funaki Y, Yatera K, Yamasue M, Komiya K, Kozawa S, Manabe H, Hozumi H, Horiguchi T, Kitajima T, Nakano Y, Nagaoka T, Hojo M, Ebihara A, Kobayashi M, Takayama K, Jinta T, Sawai T, Fukuda Y, Kaneko T, Chin K, Ogura T, Mukae H, Ishii M, Yokoyama A: Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society. Respir Investig, 62: 572-579, 2024.
20.	Tanaka K, Meguro A, Hara Y, Endo L, Izawa A, Muraoka S, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Horita N, Kato H, Kobayashi N, Takeuchi I, Nakajima A, Inoko H, Mizuki N, Kaneko T: HLA-DQA101:03 and DQB106:01 are risk factors for severe COVID-19 pneumonia. HLA, 104: e15609, 2024.
21.	Kobayashi N, Matsumoto H, Somekawa K, Kaneko A, Fukuda N, Muraoka S, Ohtsu Y, Hirata M, Nagasawa R, Kubo S, Murohashi K, Fujii H, Aoki A, Watanabe K, Horita N, Hara Y, Kaneko T: Geographic and economic influences on benralizumab prescribing for severe asthma in Japan. Sci Rep, 4: 15190, 2024.

総説

学会発行診療ガイドライン等

1.	金子猛(作成委員): 日本呼吸器学会: 喘息とCOPDのオーバーラップ（Asthma and COPD Overlap：ACO）診断と治療の手引き〔第2版〕2023, メディカルレビュー社, 2024.

著書

1.	金子猛: 咳嗽・喀痰. 日常診療に活かす診療ガイドラインUP-TO-DATE 2024-2025. メディカルレビュー社, 77-82, 2024.
2.	原悠, 金子猛(編集): 呼吸器診療エッセンシャル. 南江堂, 2024.